Brazilian variant 'worrying', says infectious diseases expert

Brazilian variant 'worrying', says infectious diseases expert

Assessment

Interactive Video

Health Sciences, Biology

University

Hard

Created by

Quizizz Content

FREE Resource

The video discusses the emergence and evolution of virus variants, focusing on the Brazilian variant. It highlights the changes in the virus's spike protein, which increase its infectiousness and potentially affect vaccine efficacy. The importance of sequencing the viral genome to track the spread of these variants is emphasized, with the UK leading in sequencing efforts. The situation in Brazil is critical, with rapid virus spread, but the exact role of the Brazilian variant is still being studied.

Read more

5 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the primary concern with the Brazilian variant of the virus?

It originated from the UK.

It has fewer changes than other variants.

It has accumulated more changes, especially in the spike protein.

It is less infectious than other variants.

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Why is the spike protein significant in the context of the virus?

It is the part of the virus that mutates the least.

It is crucial for the virus's ability to infect cells and is targeted by the immune system.

It is not involved in the virus's infectiousness.

It is not used in vaccine development.

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

How do changes in the spike protein affect the virus?

They make the virus less recognizable by the immune system.

They have no impact on the virus's infectiousness.

They make the virus less sticky.

They reduce the effectiveness of vaccines.

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the primary method to track the spread of virus variants?

By testing vaccine efficacy.

By monitoring hospital admissions.

By sequencing the viral genome.

By observing symptoms in patients.

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Why is Brazil facing challenges in managing the virus spread?

They lack sufficient genome sequencing capabilities.

They have sequenced all virus genomes.

They have no virus variants.

They have developed new tests for the virus.